TradingView
TheCryptoChartWhisperer
10. Mrz. 2022 22:05

IFRX 1D Continued Long

InflaRx N.V.NASDAQ

Beschreibung

test
Just having some fun after a great ski trip to Breckenridge, Co for a couple of weeks. Let's get back into it.

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Trade geschlossen: Ziel wurde erreicht

Mehr